<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230117057142N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-09</date_registration>
      <primary_sponsor>Zanjan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison the effectiveness of face-to-face and online psychotherapy on mild anxiety</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the efficacy of face-to-face and online Transdiagnostic therapy  on  anxiety severity,related transdiagnostic factors and therapeutic alliance in people with Sub-clinical symptoms of anxiety disorders</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-03-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68137</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The samples are randomly assigned to two test groups. Random allocation is done using Excel software.
For this purpose, in the first column, we enter 22 numbers 1 and 22 numbers 2 (respectively indicating the group (online and face-to-face integrative meta-diagnostic treatment group). Then in the second column, we generate 44 random numbers using the RAND() function. The data Based on the column values, we include random numbers sorted (ascending or descending). With this sorting, the order of placement of numbers 1 and 2 will also change and be placed randomly.
Based on the order of appearance of numbers 1 and 2, the samples are assigned to two groups, Blinding description: None of the subjects will be informed about the randomization and interpretation process of the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Social phobias. Condition 2: Panic disorder [episodic paroxysmal anxiety] without agoraphobia. Condition 3: Generalized anxiety disorder. Condition 4: Other mixed anxiety disorders. Condition 5: Phobic anxiety disorders. Condition 6: Agoraphobia, unspecified.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group face-to-face Transdiagnostic treatment group: The intervention will be implemented face-to-face and based on the Transdiagnostic therapy (Unified protocol) for adults. This protocol has 8 modules that will be implemented in 12 sessions. The protocol modules are 1 (goal selection and maintaining motivation) 2 (understanding emotions) 3 (mindfulness of emotion) 4 (cognitive flexibility) 5 (emotional behavior) 6 (understanding and dealing with bodily sensations) 7 (facing with excitement) 8 (reviewing skills and moving towards goals and maintaining achievements). The main focus of the protocol is on emotion and its three basic components, namely thoughts, physical sensations, and behavior. In the component of thoughts, the focus is on training mental errors and cognitive restructuring. In the component of bodily sensations, the techniques of awareness of bodily sensations are implemented. In the behavior component, training on the concepts of initiation and conflicting behavior is given. Finally, coping techniques with situational emotions and behavioral tests will be performed. Modals will be implemented during 12 sessions of 45 minutes for approximately 6 weeks. These modules will be distributed in the sessions according to the client's understanding and acceptance of the concepts and problems related to the preclinical symptoms of anxiety disorder, which is unique for each client. Intervention 2: The second intervention group, the online Transdiagnostic treatment group: the intervention will be implemented online and based on the Transdiagnostic therapy (Unified protocol) for adults.This protocol has 8 modules that will be implemented in 12 sessions. The protocol modules are 1 (goal selection and maintaining motivation) 2 (understanding emotions) 3 (mindfulness of emotion) 4 (cognitive flexibility) 5 (emotional behavior) 6 (understanding and dealing with bodily sensations) 7 (facing with excitement) 8 (reviewing skills and moving towards goals and maintaining achievements). The main focus of the protocol is on emotion and its three basic components, namely thoughts, physical sensations, and behavior. In the component of thoughts, the focus is on training mental errors and cognitive restructuring. In the component of bodily sensations, the techniques of awareness of bodily sensations are implemented. In the behavior component, training on the concepts of initiation and conflicting behavior is given. Finally, coping techniques with situational emotions and behavioral tests will be performed. Modals will be implemented during 12 sessions of 45 minutes for approximately 6 weeks. These modules will be distributed in the sessions according to the client's understanding and acceptance of the concepts and problems related to the preclinical symptoms of anxiety disorder, which is unique for each client.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>zeinab hasanpour pirbasti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ark Gate ,Dr. Beheshti Hospital</address>
        <city>zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1578845136</zip>
        <telephone>+98 24 3354 4001</telephone>
        <email>zeinabhassanpour78@gmail.com</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>zeinab hasanpour pirbasti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ark Gate, Dr. Beheshti Hospital</address>
        <city>zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1578845136</zip>
        <telephone>+98 24 3354 4001</telephone>
        <email>zeinabhassanpour78@gmail.com</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>having subclinical anxiety symptoms based on Beck's anxiety questionnaire (scoring 8-25)
age range between 18-50 years
not suffering from severe psychiatric disorders (psychotic spectrum, bipolar disorder)
not consuming drugs and alcohol in the last three months
Not receiving cognitive-behavioral interventions for at least eight sessions in the last five years
not receiving drug therapy within a month before the start of the intervention
the interest of the participants to participate in the research based on the provisions of the written consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having drug or alcohol addiction
suffering from severe psychiatric disorders (schizophrenia and bipolar disorder)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F40.1</hc_code>
      <hc_code>F41.0</hc_code>
      <hc_code>F41.1</hc_code>
      <hc_code>F41.3</hc_code>
      <hc_code>F40</hc_code>
      <hc_code>F40.00</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Social phobias</hc_keyword>
      <hc_keyword>Panic disorder [episodic paroxysmal anxiety] without agoraphobia</hc_keyword>
      <hc_keyword>Generalized anxiety disorder</hc_keyword>
      <hc_keyword>Other mixed anxiety disorders</hc_keyword>
      <hc_keyword>Phobic anxiety disorders</hc_keyword>
      <hc_keyword>Agoraphobia, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group face-to-face Transdiagnostic treatment group: The intervention will be implemented face-to-face and based on the Transdiagnostic therapy (Unified protocol) for adults. This protocol has 8 modules that will be implemented in 12 sessions. The protocol modules are 1 (goal selection and maintaining motivation) 2 (understanding emotions) 3 (mindfulness of emotion) 4 (cognitive flexibility) 5 (emotional behavior) 6 (understanding and dealing with bodily sensations) 7 (facing with excitement) 8 (reviewing skills and moving towards goals and maintaining achievements). The main focus of the protocol is on emotion and its three basic components, namely thoughts, physical sensations, and behavior. In the component of thoughts, the focus is on training mental errors and cognitive restructuring. In the component of bodily sensations, the techniques of awareness of bodily sensations are implemented. In the behavior component, training on the concepts of initiation and conflicting behavior is given. Finally, coping techniques with situational emotions and behavioral tests will be performed. Modals will be implemented during 12 sessions of 45 minutes for approximately 6 weeks. These modules will be distributed in the sessions according to the client's understanding and acceptance of the concepts and problems related to the preclinical symptoms of anxiety disorder, which is unique for each client.</i_keyword>
      <i_keyword>The second intervention group, the online Transdiagnostic treatment group: the intervention will be implemented online and based on the Transdiagnostic therapy (Unified protocol) for adults.This protocol has 8 modules that will be implemented in 12 sessions. The protocol modules are 1 (goal selection and maintaining motivation) 2 (understanding emotions) 3 (mindfulness of emotion) 4 (cognitive flexibility) 5 (emotional behavior) 6 (understanding and dealing with bodily sensations) 7 (facing with excitement) 8 (reviewing skills and moving towards goals and maintaining achievements). The main focus of the protocol is on emotion and its three basic components, namely thoughts, physical sensations, and behavior. In the component of thoughts, the focus is on training mental errors and cognitive restructuring. In the component of bodily sensations, the techniques of awareness of bodily sensations are implemented. In the behavior component, training on the concepts of initiation and conflicting behavior is given. Finally, coping techniques with situational emotions and behavioral tests will be performed. Modals will be implemented during 12 sessions of 45 minutes for approximately 6 weeks. These modules will be distributed in the sessions according to the client's understanding and acceptance of the concepts and problems related to the preclinical symptoms of anxiety disorder, which is unique for each client.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Score in Beck's Anxiety Questionnaire. Timepoint: The measurement will be done in three periods: before the intervention and after the end of the intervention and three months after the end of the interventionبرای. Method of measurement: Beck's anxiety questionnaire will be used for the variable of anxiety, and the subject's score in the range of 8-25 indicates the presence of subclinical symptoms of anxiety.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Repetitive negative thoughts: their main characteristic is being repetitive, disturbing and unwanted. Timepoint: The measurement will be done in three periods: before the intervention and after the end of the intervention and three months after the end of the intervention. Method of measurement: For the Repetitive negative thoughts variable, the Repetitive negative thoughts questionnaire will be used, which includes 10 questions.</sec_outcome>
      <sec_outcome>Anxiety sensitivity. Timepoint: The measurement will be done in three periods: before the intervention and after the end of the intervention and three months after the end of the intervention. Method of measurement: The anxiety sensitivity questionnaire is a 16-item self-report questionnaire. The said questionnaire has 16 items and 3 subscales: physical concerns, fear of losing cognitive control, and fear of anxiety being observed by others.</sec_outcome>
      <sec_outcome>Positive and Negative Affect. Timepoint: The measurement will be done in three periods: before the intervention and after the end of the intervention and three months after the end of the intervention. Method of measurement: The positive and negative affect scale is a 20-word instrument designed to measure two mood dimensions, namely positive affect and negative affect.</sec_outcome>
      <sec_outcome>Therapeutic alliance. Timepoint: The client and therapist versions of the therapeutic alliance Questionnaire are completed in the 6th session and the 12th session. Method of measurement: The Work Alliance Questionnaire is a questionnaire that includes two forms, client and therapist versions. Each version contains 12 questions and is scored on a Likert scale from 1 to 5. One of the most common tools for evaluating the quality of therapeutic alliance is the working alliance questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-01-11</approval_date>
        <contact_name>Research Ethics Committee of Zanjan University of Medical Sciences</contact_name>
        <contact_address>Zanjan University of Medical Sciences , Mahdavi Blv, shahrak karmandan zanjan Zanjan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
